BASF Sells 3 Drug Ingredients Plants To Siegfried For $304M
German chemicals giant BASF will sell certain pharmaceutical ingredients businesses to Swiss company Siegfried Holding AG for €270 million ($304 million), a move BASF said enables it to focus on core...To view the full article, register now.
Already a subscriber? Click here to view full article